Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Voxel-based Morphometry Study of Grey Matter Volume Changes in Neuromyelitis Optica Patients.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool.
Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates.
Environmental factors in multiple sclerosis.
Lower urinary tract symptoms of neurological origin in urological practice.
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.
Natalizumab in the treatment of pediatric multiple sclerosis.
Hughes syndrome and Multiple sclerosis.
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Outcomes after Percutaneous Surgery for Patients with Multiple Sclerosis Related Trigeminal Neuralgia.
Neuroimmunology: Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica.
Optic Neuritis, its Differential Diagnosis and Management.
Acute disseminated encephalomyelitis (ADEM) following a H3N3 parainfluenza virus infection in a pregnant asthmatic woman with respiratory failure.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
Pages
« first
‹ previous
…
290
291
292
293
294
295
296
297
298
…
next ›
last »